NCT07144306

AI-Driven Early Detection of Skin Cancer

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: Nuvana Healthcare LTD · Industry
• Sex: All
• Age: 18 Months
• Healthy volunteers: Accepted

Summary

This study evaluates the feasibility and accuracy of an AI-powered mobile platform (NuvanaDx) for early detection of skin cancer, including melanoma, using smartphone-based imaging. The platform is designed to improve access to early diagnosis, reduce waiting times, and support triage into appropriate care pathways.

Detailed description

The study will collect retrospective and prospective anonymized skin lesion images and metadata to validate the AI algorithm against dermatology-confirmed diagnoses. The aim is to determine sensitivity, specificity, and predictive value of the AI tool across diverse populations and skin tones. The study will also assess user experience, accessibility, and integration into clinical care pathways.

Conditions

• Skin Cancer Melanoma

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Smartphone-based AI skin lesion analysis (NuvanaDx platform).	Smartphone-based AI skin lesion analysis (NuvanaDx platform).

Timeline

• Start date: 2025-10-01
• Primary completion: 2025-12-01
• Completion: 2026-01-01
• First posted: 2025-08-27
• Last updated: 2025-09-26

Locations

1 site across 1 country: United Kingdom